Rancho BioSciences (United States)

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Blood · 2018 · 478 citations · Full text

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Leukemia · 2018 · 440 citations · Full text

The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

Ruili Huang, Ivan Grishagin, Yuhong Wang et al. · Frontiers in Pharmacology · 2019 · 301 citations · Full text

Environmental Signaling, Integrated Platform, Molecular Biology +26

Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder

Gwenaël G. R. Leday, Petra E. Vértes, Sylvia Richardson et al. · Biological Psychiatry · 2017 · 220 citations · Full text

Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

Sarah Gooding, Naser Ansari‐Pour, Fadi Towfic et al. · Blood · 2020 · 151 citations · Full text